RECOVERY is a randomised trial investigating whether treatment with Lopinavir-Ritonavir,
Hydroxychloroquine, Corticosteroids, Azithromycin, Colchicine, IV Immunoglobulin (children
only), Convalescent plasma, Synthetic neutralizing antibodies (REGN-COV2), Tocilizumab,
Aspirin, Baricitinib, Infliximab, Empagliflozin or Anakinra (children only) prevents death in
patients with COVID-19.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Oxford
Collaborators:
Bill and Melinda Gates Foundation Department for International Development, United Kingdom Health Data Research UK Medical Research Council Population Health Research Unit National Institute for Health Research, United Kingdom NIHR Clinical Trials Unit Support Funding NIHR Health Protection Research Unit in Emerging and Zoonotic Infections UK Research and Innovation Wellcome